Interesting although slightly controversial study. I don't think there are many studies comparing the efficacy of different flavonoids. My summary is given below.
British Journal of Nutrition , Accepted manuscript , pp. 1 - 30
DOI: doi.org/10.1017/S0007114521...
This population-based case-control study was carried out in Mexico City and used food-frequency questionnaires over 3 years. A database was used to estimate the daily intake (mg/d) of flavanoids for 395 confirmed incident PC cases and 797 population controls matched by age (±5 years). Three flavanoid dietary intake patterns were determined through principal component analysis, and their association with PC was estimated using logistic regression models. Three flavanoids patterns were identified as:
1. The Gallate pattern (GP) characterized by (-)-epicatechin-3-O-gallate, (-)-epigallocatechin-3-O-gallate and (+)-gallocatechin;
2. The Luteolin pattern (LP) characterized by luteolin and (-)-epigallocatechin-3-O-gallate;
3. The mixed pattern (MP) that included (+)-catechin, (-) -epicatechin, and quercetin.
Results
A higher GP intake (OR T3 vs.T1=0.47; 95% CI 0.33-0.66) was associated with a decreased PC likelihood.
A higher LP intake (OR T3 vs. T1=0.39; 95% CI 0.27-0.59) was associated with a decreased PC likelihood.
In contrast, a higher MP intake (OR T3 vs. T1=2.32; 95% CI 1.67-3.23) was associated with increased PC likelihood.
They took account of potential confounders such as educational level, history of chronic disease, history of sexually transmitted disease, history of prostate cancer in first-degree relatives, leisure-time physical activity and smoking patterns and consumption of raw tomato, green-yellow leafy vegetables and green-yellow nonleafy vegetables.
I don't know why they took account of raw tomatoes but not cooked tomatoes!
A sensitivity analysis was performed, adjusting each flavonoid intake pattern model with each of the other patterns.
There is no mention of whether any analysis was made of whether particular foods high in the individual flavanoids were generally consumed in conjunction with healthy or unhealthy foods. For example if the MP flavanoid foods were often consumed with high saturated fat, processed meat or high sugar foods. Conversely, perhaps the use of foods high in GP or LP flavonoids might be associated with the use of other more healthy foods.
The study concluded that their findings support the existing evidence of the anticarcinogenic capacity of some flavonoids, particularly (-)-epigallocatechin-3-O-gallate and luteolin. However, well-designed clinical trials are needed to further demonstrate their beneficial effects.